Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vycor MedicalVYCO EV-to-FCF is 27.52 as of Jul. 22, 2026. The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Vycor Medical ranks worse than 57.97% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vycor Medical's Enterprise Value is $3.11 Mil.
Vycor Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11 Mil. Therefore, Vycor Medical's EV-to-FCF for today is 27.52.
The historical rank and industry rank for Vycor Medical's EV-to-FCF or its related term are showing as below:
VYCO'
s EV-to-FCF Range Over the Past 10 Years
Min: -959.74 Med: -16.14 Max: 744.61
Current: 27.52
During the past 13 years, the highest EV-to-FCF of Vycor Medical was 744.61. The lowest was -959.74. And the median was -16.14.
VYCO's EV-to-FCF is ranked worse than 57.97% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.145
vs VYCO: 27.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vycor Medical's PE Ratio (TTM) for today is calculated as:
Vycor Medical's share price for today is $0.069.
Vycor Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Vycor Medical EV-to-FCF Related Terms
Vycor Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Vycor Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vycor Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Vycor Medical's EV-to-FCF falls into.
Vycor Medical's current Enterprise Value is $3.11 Mil.
Vycor Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a EV-to-FCF of 27.52 as of Jul. 22, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vycor Medical and its competitors. According to the industry distribution chart, Vycor Medical ranks #240 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 58%.
Is Vycor Medical's EV-to-FCF too high?
Vycor Medical's current EV-to-FCF is 27.52. The Medical Devices & Instruments industry median EV-to-FCF is 23.15. Vycor Medical's value of 27.52 is 18.9% above this industry median. Based on the distribution chart, Vycor Medical ranks #240 out of 414 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Vycor Medical's EV-to-FCF compare to AEMD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #240 out of 414 companies for EV-to-FCF. This places Vycor Medical in the lower half of its industry. The industry median EV-to-FCF is 23.15. Vycor Medical's value of 27.52 is 18.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.15, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vycor Medical's current EV-to-FCF of 27.52 is 18.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vycor Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vycor Medical's current EV-to-FCF is 27.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.07 — trading 42.5% below its estimated fair value. The current EV-to-FCF is 27.52 and 18.9% above the Medical Devices & Instruments industry median of 23.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Vycor Medical (VYCO), the current EV-to-FCF is 27.52 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
